Literature DB >> 25520149

Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function.

Thomas M Daly1, Harry R Hill2.   

Abstract

Pneumococcal vaccination is a commonly used technique for assessing the humoral immune status of a patient suspected of having immunodeficiency. Interpretation of what constitutes an adequate response, however, can be challenging. This is due to the complexity of the data generated from serotype-specific assays, historical variations in the assays used to measure pneumococcal antibodies, and varying recommendations on the relevant cut points that define response. In this review, we summarize the historical evolution of assays used for this purpose and discuss the analytical considerations that have influenced published data. We also examine current clinical recommendations for defining an adequate response to vaccination, with a particular focus on the interpretation of serotype-specific data generated by multiplex assays.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25520149      PMCID: PMC4308869          DOI: 10.1128/CVI.00735-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

Review 1.  Pneumococcal vaccine and patients with pulmonary diseases.

Authors:  Mehdi Mirsaeidi; Golnaz Ebrahimi; Mary Beth Allen; Stefano Aliberti
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

2.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Authors:  S Black; H Shinefield; B Fireman; E Lewis; P Ray; J R Hansen; L Elvin; K M Ensor; J Hackell; G Siber; F Malinoski; D Madore; I Chang; R Kohberger; W Watson; R Austrian; K Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

3.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

4.  Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

Authors:  S Choo; L Seymour; R Morris; S Quataert; S Lockhart; K Cartwright; A Finn
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

5.  Invasive pneumococcal disease in England and Wales: vaccination implications.

Authors:  K Sleeman; K Knox; R George; E Miller; P Waight; D Griffiths; A Efstratiou; K Broughton; R T Mayon-White; E R Moxon; D W Crook
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

6.  A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides.

Authors:  Jerry W Pickering; Thomas B Martins; Ryan W Greer; M Carl Schroder; Mark E Astill; Christine M Litwin; Stephen W Hildreth; Harry R Hill
Journal:  Am J Clin Pathol       Date:  2002-04       Impact factor: 2.493

7.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

8.  Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma.

Authors:  N Lahood; S S Emerson; P Kumar; R U Sorensen
Journal:  Ann Allergy       Date:  1993-04

9.  A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques.

Authors:  G Schiffman; R M Douglas; M J Bonner; M Robbins; R Austrian
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

Review 10.  Assessment of the antibody response to pneumococcal vaccine in high-risk populations.

Authors:  S H Landesman; G Schiffman
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  21 in total

1.  The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies.

Authors:  Peter Jandus; Kayluz Frias Boligan; David F Smith; Elisabeth de Graauw; Bodo Grimbacher; Camilla Jandus; Mai M Abdelhafez; Alain Despont; Nicolai Bovin; Dagmar Simon; Robert Rieben; Hans-Uwe Simon; Richard D Cummings; Stephan von Gunten
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

2.  Discrepant serological assays for Pneumococcus in renal transplant recipients - a prospective study.

Authors:  Jay A Fishman; David N Iklé; Robert A Wilkinson
Journal:  Transpl Int       Date:  2017-05-02       Impact factor: 3.782

3.  Immunogenicity of 13-Valent Conjugate Pneumococcal Vaccine in Patients 50 Years and Older with End-Stage Renal Disease and on Dialysis.

Authors:  Subhashis Mitra; Gary E Stein; Shyam Bhupalam; Daniel H Havlichek
Journal:  Clin Vaccine Immunol       Date:  2016-11-04

4.  Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model.

Authors:  Y H Sheen; G Rajagopalan; C M Snapper; H Kita; C-I Wi; P J Umaretiya; Y J Juhn
Journal:  HLA       Date:  2016-08-10       Impact factor: 4.513

5.  The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency.

Authors:  Lisanne M A Janssen; Michiel Heron; Jean-Luc Murk; Alexander C A P Leenders; Ger T Rijkers; Esther de Vries
Journal:  Clin Exp Immunol       Date:  2021-06-01       Impact factor: 4.330

6.  Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.

Authors:  Giorgia Bucciol; Heidi Schaballie; Rik Schrijvers; Barbara Bosch; Marijke Proesmans; Kris De Boeck; Mieke Boon; François Vermeulen; Natalie Lorent; Doreen Dillaerts; Bjørn Kantsø; Charlotte Svaerke Jørgensen; Marie-Paule Emonds; Xavier Bossuyt; Leen Moens; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2019-11-08       Impact factor: 8.542

7.  The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.

Authors:  Johanna Nagel; Pierre Geborek; Tore Saxne; Göran Jönsson; Martin Englund; Ingemar F Petersson; Jan-Åke Nilsson; Lennart Truedsson; Meliha C Kapetanovic
Journal:  Arthritis Res Ther       Date:  2015-05-19       Impact factor: 5.156

8.  Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies.

Authors:  Benjamin Lopez; Mathilde Bahuaud; Claire Fieschi; Souad Mehlal; Mohamed Jeljeli; Stéphanie Rogeau; Séverine Brabant; Anne-Sophie Deleplancque; Sylvain Dubucquoi; Sandrine Poizot; Louis Terriou; David Launay; Frédéric Batteux; Myriam Labalette; Guillaume Lefèvre
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

Review 9.  Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma.

Authors:  Mary Claire Rolfes; Young Jun Juhn; Chung-Il Wi; Youn Ho Sheen
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-03-31

10.  Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.

Authors:  Elisa V Gomez; Jessie L Bishop; Kimberley Jackson; Talia M Muram; Diane Phillips
Journal:  BioDrugs       Date:  2017-12       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.